November 26, 2025.
New York, NY — November 27, 2025 — Leads & Copy — Genvor Inc. (OTCQB: GNVR), an agricultural biotechnology firm that develops sustainable crop-protection solutions, has joined the B2i Digital platform as a Featured Company, according to a recent announcement.
Based in Woodland, California, Genvor utilizes an AI-accelerated peptide design to create its crop-protection solutions. Founded in 2018, the company’s antimicrobial, insecticidal, and nutrient-enhancing peptides are built on its proprietary BioCypher Algorithm, targeting the estimated $220 billion in annual global crop losses caused by plant pathogens.
David Shapiro, CEO of B2i Digital, expressed his enthusiasm for the partnership, noting Genvor’s leadership and their clear articulation of the growing demand for biological solutions in agriculture. He said B2i Digital will assist Genvor in reaching interested investors through its multi-channel digital marketing engine and targeted outreach campaigns.
Genvor’s BioCypher Algorithm leverages over 50,000 designed peptides and 30 years of foundational research. The platform has demonstrated broad-spectrum efficacy, including 76%–98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species.
Chad Pawlak, CEO of Genvor, stated that expanding investor engagement is crucial at this time because of the momentum from recently issued patents, active partnership discussions, and a growing pipeline. Pawlak added he looks forward to leveraging B2i Digital’s platform to connect with investors who understand the growing demand for sustainable crop protection and the value of Genvor’s licensing-first business model.
Genvor’s intellectual property portfolio includes two issued U.S. patents and one pending application covering 24 proprietary peptides. The company recently announced the issuance of U.S. Patent No. 12,458,684 for transgenic corn expressing antifungal peptide AGM182, co-assigned to Genvor Inc. and the United States Department of Agriculture (USDA). The patent validates the commercial potential of Genvor’s seed-trait technologies for major row crops.
Genvor’s development pipeline spans multiple crops, including corn, citrus, rice, soybeans, cotton, flax, and potato. The company is currently engaged with major agricultural companies on joint venture evaluations and commercialization discussions.
B2i Digital, Inc. was founded in 2021 by former Maxim Group Investment Banker and Chief Marketing Officer David Shapiro and is headquartered in New York City. It is a digital marketing and investor-awareness platform. B2i Digital partners with leading investor conferences, public companies, and capital-markets advisors through its Featured Conference, Featured Company, and Featured Expert programs.
Genvor Incorporated is pioneering the future of sustainable agriculture through its proprietary AI-accelerated peptide design platform that transforms single discoveries into multi-crop protection and optimization opportunities across diverse agricultural environments. With multiple patents and proprietary peptides in active development, Genvor offers ready-to-deploy licensing opportunities that integrate with existing production infrastructure and regulatory frameworks.
David Shapiro
Chief Executive Officer
B2i Digital, Inc.
212.579.4844
david@b2idigital.com
Investor Relations
Genvor Incorporated
715.903.6473
investors@genvor.com
Source: Genvor Incorporated
